Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Breast Cancer

  Free Subscription


Articles published in Gene

Retrieve available abstracts of 64 articles:
HTML format
Text format



Single Articles


    February 2020
  1. DAI J, Chen Y, Gong Y, Gu D, et al
    Association of microRNA-27a rs895819 polymorphism with the risk of cancer: An updated meta-analysis.
    Gene. 2020;728:144185.
    PubMed     Text format     Abstract available


  2. RAHMANI F, Ferns GA, Talebian S, Nourbakhsh M, et al
    Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer.
    Gene. 2020 Feb 8:144459. doi: 10.1016/j.gene.2020.144459.
    PubMed     Text format     Abstract available


  3. ABUBAKR BABTEEN N, Fawzy MS, Alelwani W, Ayiad Alharbi R, et al
    Signal peptide missense variant in cancer-brake gene CTLA4 and breast cancer outcomes.
    Gene. 2020 Feb 7:144435. doi: 10.1016/j.gene.2020.144435.
    PubMed     Text format     Abstract available


  4. NAJJARY S, Mohammadzadeh R, Mokhtarzadeh A, Mohammadi A, et al
    Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer.
    Gene. 2020 Feb 5:144453. doi: 10.1016/j.gene.2020.144453.
    PubMed     Text format     Abstract available


    January 2020
  5. ZHANG H, Cui X, Cao A, Li X, et al
    ITGA3 interacts with VASP to regulate stemness and epithelial-mesenchymal transition of breast cancer cells.
    Gene. 2020 Jan 25:144396. doi: 10.1016/j.gene.2020.144396.
    PubMed     Text format     Abstract available


  6. POURBAGHER R, Akhavan-Niaki H, Jorsaraei SGA, Fattahi S, et al
    Targeting LA7 breast cancer stem cells of rat through repressing the genes of stemness-related transcription factors using three different biological fluids.
    Gene. 2020 Jan 21:144381. doi: 10.1016/j.gene.2020.144381.
    PubMed     Text format     Abstract available


  7. WANG X, Su D, Qin Z, Chen Z, et al
    Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling.
    Gene. 2020;722:144057.
    PubMed     Text format     Abstract available


    December 2019
  8. DASTMALCHI N, Safaralizadeh R, Baradaran B, Hosseinpourfeizi M, et al
    An update review of deregulated tumor suppressive microRNAs and their contribution in various molecular subtypes of breast cancer.
    Gene. 2019 Dec 26:144301. doi: 10.1016/j.gene.2019.144301.
    PubMed     Text format     Abstract available


  9. XIE W, Zhang H, Qin S, Zhang J, et al
    The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
    Gene. 2019;720:144088.
    PubMed     Text format     Abstract available


  10. AL-EITAN LN, Rababa'h DM
    Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: a genotype-phenotype study.
    Gene. 2019 Dec 10:144281. doi: 10.1016/j.gene.2019.144281.
    PubMed     Text format     Abstract available


    November 2019
  11. MORAIS-RODRIGUES F, Silv Erio-Machado R, Kato RB, Rodrigues DLN, et al
    Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression.
    Gene. 2019 Nov 21:144168. doi: 10.1016/j.gene.2019.144168.
    PubMed     Text format     Abstract available


    September 2019
  12. QI L, Yao Y, Zhang T, Feng F, et al
    A four-mRNA model to improve the prediction of breast cancer prognosis.
    Gene. 2019 Sep 4:144100. doi: 10.1016/j.gene.2019.144100.
    PubMed     Text format     Abstract available


  13. ZOU X, Li M, Huang Z, Zhou X, et al
    Circulating miR-532-502 cluster derived from chromosome X as biomarkers for diagnosis of breast cancer.
    Gene. 2019 Sep 4:144104. doi: 10.1016/j.gene.2019.144104.
    PubMed     Text format     Abstract available


    August 2019
  14. WANG H, Xu B, Shi J
    N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
    Gene. 2019 Aug 24:144076. doi: 10.1016/j.gene.2019.144076.
    PubMed     Text format     Abstract available


  15. ORS KUMOGLU G, Doskaya M, Gulce Iz S
    The biomarker features of miR-145-3p determined via meta-analysis validated by qRT-PCR in metastatic cancer cell lines.
    Gene. 2019;710:341-353.
    PubMed     Text format     Abstract available


  16. NAZIR SU, Kumar R, Singh A, Khan A, et al
    Corrigendum to "Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor" [Gene 711 (2019) 143952].
    Gene. 2019 Aug 1:144013. doi: 10.1016/j.gene.2019.144013.
    PubMed     Text format    


    July 2019
  17. TOKGUN PE, Tokgun O, Kurt S, Tomatir AG, et al
    MYC-driven regulation of long non-coding RNA profiles in breast cancer cells.
    Gene. 2019 Jul 18:143955. doi: 10.1016/j.gene.2019.143955.
    PubMed     Text format     Abstract available


  18. RAMEZANI S, Sharafshah A, Mirzanejad L, Hadavi M, et al
    Association of PARP1 rs4653734, rs907187 and rs1136410 variants with breast cancer risk among Iranian women.
    Gene. 2019;712:143954.
    PubMed     Text format     Abstract available


    June 2019
  19. NAZIR SU, Kumar R, Singh A, Khan A, et al
    Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor.
    Gene. 2019 Jun 29:143952. doi: 10.1016/j.gene.2019.143952.
    PubMed     Text format     Abstract available


  20. YARAHMADI S, Abdolvahabi Z, Hesari Z, Tavakoli-Yaraki M, et al
    Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells.
    Gene. 2019 Jun 17. pii: S0378-1119(19)30589-X. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available


  21. FENG T, Zhang P, Sun Y, Wang Y, et al
    High throughput sequencing identifies breast cancer-secreted exosomal LncRNAs initiating pulmonary pre-metastatic niche formation.
    Gene. 2019 Jun 6. pii: S0378-1119(19)30552-9. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available


  22. KASA P, Farran B, Prasad GLV, Nagaraju GP, et al
    Aquaporins in female specific cancers.
    Gene. 2019;700:60-64.
    PubMed     Text format     Abstract available


    May 2019
  23. XU X, Yang J, Zhou W, Wang L, et al
    Genetic variations within alternative splicing associated genes are associated with breast cancer susceptibility in Chinese women.
    Gene. 2019 May 9. pii: S0378-1119(19)30484-6. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available


    April 2019
  24. WU G, Niu M, Qin J, Wang Y, et al
    Inactivation of Rab27B-dependent signaling pathway by calycosin inhibits migration and invasion of ER-negative breast cancer cells.
    Gene. 2019 Apr 16. pii: S0378-1119(19)30344-0. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available


  25. BU Y, Shi L, Yu D, Liang Z, et al
    CDCA8 is a key mediator of estrogen-stimulated cell proliferation in breast cancer cells.
    Gene. 2019;703:1-6.
    PubMed     Text format     Abstract available


    March 2019
  26. MUKUND V, Saddala MS, Farran B, Mannavarapu M, et al
    Molecular docking studies of angiogenesis target protein HIF-1alpha and genistein in breast cancer.
    Gene. 2019;701:169-172.
    PubMed     Text format     Abstract available


  27. SAFARI MR, Rezaei FM, Dehghan A, Noroozi R, et al
    Genomic variants within the long non-coding RNA H19 confer risk of breast cancer in Iranian population.
    Gene. 2019 Mar 22. pii: S0378-1119(19)30293-8. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available


  28. AFSHAR E, Hashemi-Arabi M, Salami S, Peirouvi T, et al
    Screening of acetaminophen-induced alterations in epithelial-to-mesenchymal transition-related expression of microRNAs in a model of stem-like triple-negative breast cancer cells: The possible functional impacts.
    Gene. 2019 Mar 18. pii: S0378-1119(19)30271-9. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available


  29. ZHANG L, Chen T, Yan L, Xu H, et al
    MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer.
    Gene. 2019 Mar 13. pii: S0378-1119(19)30200-8. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available


    February 2019
  30. YOUNES N, Zayed H
    Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review.
    Gene. 2019;684:154-164.
    PubMed     Text format     Abstract available


    January 2019
  31. ZHONG C, Mai Y, Gao H, Zhou W, et al
    Mitochondrial targeting of TR3 is involved in TPA induced apoptosis in breast cancer cells.
    Gene. 2019 Jan 11. pii: S0378-1119(19)30032-0. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    November 2018
  32. LI J, Li B, Jiang Q, Zhang Y, et al
    Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.
    Gene. 2018;677:211-227.
    PubMed     Text format     Abstract available


  33. ORANGI E, Motovali-Bashi M
    Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
    Gene. 2018;687:272-279.
    PubMed     Text format     Abstract available


    October 2018
  34. ZHOU J, Pei Y, Chen G, Cao C, et al
    SPC24 Regulates breast cancer progression by PI3K/AKT signaling.
    Gene. 2018;675:272-277.
    PubMed     Text format     Abstract available


  35. MA R, Zhai X, Zhu X, Zhang L, et al
    LINC01585 functions as a regulator of gene expression by the CAMP/CREB signaling pathway in breast cancer.
    Gene. 2018 Oct 23. pii: S0378-1119(18)31102-8. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  36. JAHANGIRI R, Jamialahmadi K, Gharib M, Razavi AE, et al
    Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
    Gene. 2018 Oct 22. pii: S0378-1119(18)31099-0. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  37. SHI S, Chen X, Liu H, Yu K, et al
    LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/beta-catenin pathway.
    Gene. 2018 Oct 6. pii: S0378-1119(18)31039-4. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    August 2018
  38. MAQBOOL SN, Nazeer HS, Rafiq M, Javed A, et al
    Bridging the gap by discerning SNPs in linkage disequilibrium and their role in breast cancer.
    Gene. 2018 Aug 14. pii: S0378-1119(18)30762-5. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  39. JANAKI RAMAIAH M, Vaishnave S
    BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
    Gene. 2018 Aug 7. pii: S0378-1119(18)30872-2. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    July 2018
  40. SHERAFATIAN M
    Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
    Gene. 2018 Jul 25. pii: S0378-1119(18)30836-9. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  41. SADAF, Habib M, Khan MA, Najm MZ, et al
    Hypermethylated LATS2 gene with decreased expression in female breast cancer: A case control study from North India.
    Gene. 2018 Jul 12. pii: S0378-1119(18)30807-2. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  42. JIANG M, Xiao Y, Liu D, Luo N, et al
    Overexpression of long noncoding RNA LINC01296 indicates an unfavorable prognosis and promotes tumorigenesis in breast cancer.
    Gene. 2018 Jul 4. pii: S0378-1119(18)30773-X. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    June 2018
  43. AL-OTHMAN N, Hammad H, Ahram M
    Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells.
    Gene. 2018 Jun 28. pii: S0378-1119(18)30755-8. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  44. ULKER D, Ersoy YE, Gucin Z, Muslumanoglu M, et al
    Downregulation of SCARA5 may contribute to breast cancer via promoter hypermethylation.
    Gene. 2018 Jun 13. pii: S0378-1119(18)30687-5. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  45. HESARI Z, Nourbakhsh M, Hosseinkhani S, Abdolvahabi Z, et al
    Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells.
    Gene. 2018 Jun 7. pii: S0378-1119(18)30672-3. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    May 2018
  46. XU J, Zhang W, Tang L, Chen W, et al
    Epithelial-mesenchymal transition induced PAI-1 is associated with prognosis of triple-negative breast cancer patients.
    Gene. 2018 May 23. pii: S0378-1119(18)30586-9. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  47. RAHMAN S, Zayed H
    Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRCA1/2 genes.
    Gene. 2018 May 16. pii: S0378-1119(18)30534-1. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  48. BAGHI N, Bakhshinejad B, Keshavarz R, Babashah S, et al
    Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells.
    Gene. 2018 May 10. pii: S0378-1119(18)30508-0. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  49. REZAIE Z, Ardeshirylajimi A, Ashkezari MD
    Improved anticancer properties of stem cells derived exosomes by prolonged release from PCL nanofibrous structure.
    Gene. 2018 May 2. pii: S0378-1119(18)30480-3. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    March 2018
  50. FEI HR, Li ZJ, Ying-Zhang, Yue-Liu, et al
    HBXIP regulates etoposide-induced cell cycle checkpoints and apoptosis in MCF-7 human breast carcinoma cells.
    Gene. 2018;647:39-47.
    PubMed     Text format     Abstract available


  51. RAGHAVAN S, Venkatraman G, Rayala SK
    Cloning and functional characterization of human Pak1 promoter by steroid hormones.
    Gene. 2018;646:120-128.
    PubMed     Text format     Abstract available


  52. XIAO B, Zhang W, Chen L, Hang J, et al
    Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Gene. 2018 Mar 5. pii: S0378-1119(18)30238-5. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    February 2018
  53. HEYDARI N, Nikbakhsh N, Sadeghi F, Farnoush N, et al
    Overexpression of serum MicroRNA-140-3p in premenopausal women with newly diagnosed breast cancer.
    Gene. 2018 Feb 20. pii: S0378-1119(18)30167-7. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  54. SINGH PK, Mistry K, Haritha C, Rank DN, et al
    Exploring the deleterious SNPs in XRCC4 gene using computational approach and studying their association with breast cancer in the population of West India.
    Gene. 2018 Feb 13. pii: S0378-1119(18)30176-8. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  55. GHALI R, Al-Mutawa MA, Al-Ansari AK, Zaied S, et al
    Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
    Gene. 2018 Feb 4. pii: S0378-1119(18)30140-9. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  56. LI XP, Lan JY, Liu DQ, Zhou H, et al
    OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.
    Gene. 2018 Feb 1. pii: S0378-1119(18)30121-5. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    January 2018
  57. CHEN J, Jiang Y, Zhou J, Liu S, et al
    Evaluation of CpG-SNPs in miRNA promoters and risk of breast cancer.
    Gene. 2018 Jan 24. pii: S0378-1119(18)30085-4. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


  58. DANESH H, Hashemi M, Bizhani F, Hashemi SM, et al
    Association study of miR-100, miR-124-1, miR-218-2, miR-301b, miR-605, and miR-4293 polymorphisms and the risk of breast cancer in a sample of Iranian population.
    Gene. 2018 Jan 6. pii: S0378-1119(18)30032-5. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    December 2017
  59. KAR S, Patra SK
    Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Gene. 2017 Dec 1. pii: S0378-1119(17)31043-0. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    November 2017
  60. KLASSEN LMB, Chequin A, Manica GCM, Biembengut IV, et al
    MMP9 gene expression regulation by intragenic epigenetic modifications in breast cancer.
    Gene. 2017 Nov 18. pii: S0378-1119(17)31018-1. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


  61. PENG R, Luo C, Guo Q, Cao J, et al
    Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population.
    Gene. 2017 Nov 13. pii: S0378-1119(17)30956-3. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    October 2017
  62. JANAKI RAMAIAH M, Naushad SM, Lavanya PON, Gayatri A, et al
    Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
    Gene. 2017 Oct 13. pii: S0378-1119(17)30831-4. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


  63. ZHOU L, Gao HF, Liu DS, Feng JY, et al
    Gene expression profiling of brain metastatic cell from triple negative breast cancer: Understanding the molecular events.
    Gene. 2017 Oct 9. pii: S0378-1119(17)30833-8. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    September 2017
  64. LAHIRI DK, Maloney B, Sambamurti K
    When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's author.
    Gene. 2017 Sep 6. pii: S0378-1119(17)30646-7. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: